BANK OF AMERICA CORP /DE/ - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 29 filers reported holding APREA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$40118
-40.4%
0.00%
Q2 2022$0
-100.0%
198
-95.3%
0.00%
Q1 2022$8,0004,183
+2887.9%
0.00%
Q4 2021$0
-100.0%
140
-98.6%
0.00%
Q3 2021$53,000
+96.3%
10,306
+83.5%
0.00%
Q2 2021$27,000
-41.3%
5,616
-37.6%
0.00%
Q1 2021$46,000
+206.7%
9,004
+210.1%
0.00%
Q4 2020$15,000
-99.3%
2,904
-96.6%
0.00%
Q3 2020$2,070,000
+2.3%
86,046
+64.9%
0.00%
Q2 2020$2,024,000
+9.5%
52,178
-1.9%
0.00%
Q1 2020$1,848,000
+3596.0%
53,171
+4716.2%
0.00%
Q4 2019$50,0001,1040.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders